Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Flumazenil to Antagonize RemimazolamRemimazolamRenal Transplantation
Interventions
DRUG

Flumazenil Injection(F1 group)

Flumazenil Injection(F1 group): Immediately after surgery, 0.5 mg flumazenil was administered, followed by an equal volume of saline (equal to the volume of 0.3 mg flumazenil) 25 minutes later.

DRUG

Flumazenil Injection(F2 group)

Flumazenil Injection(F2 group): Immediately after surgery, 0.5 mg flumazenil was administered, followed by 0.3 mg flumazenil 25 minutes later.

DRUG

Saline(C group)

Flumazenil Injection(F2 group): Immediately after surgery, an equal volume of saline (equal to the volume of 0.5 mg flumazenil) was administered, followed by an equal volume of saline (equal to the volume of 0.3 mg flumazenil) 25 minutes later.

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER

NCT06531369 - Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients | Biotech Hunter | Biotech Hunter